FIELD: medicine, oncology.
SUBSTANCE: the present innovation deals with prescribing betaleukin daily for 5 d at the dosage of 5 ng/kg patient's body weight/500 ml isotonic sodium chloride solution as intravenous drop infusions of about 60-120 min duration just before the onset of specific anti-tumor therapy at applying polychemotherapy. Application of betaleukin normalizes functional activity of immunocompetent cells and decreases side effects of cytostatics.
EFFECT: higher efficiency of therapy.
4 tbl
Title | Year | Author | Number |
---|---|---|---|
IMMUNOMODULATING PREPARATION "BETALEUKIN" | 1998 |
|
RU2128706C1 |
TREATMENT METHOD OF PATIENTS WITH BREAST CANCER | 2008 |
|
RU2368407C1 |
METHOD OF COMBINATION TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OPERABLE OESOPHAGEAL CANCER | 2009 |
|
RU2424007C1 |
METHOD OF COMBINED TREATMENT OF PATIENTS WITH LOCALLY SPREAD RESECTABLE ESOPHAGEAL CANCER | 2009 |
|
RU2419391C1 |
METHOD FOR APPLYING COMBINED TREATMENT OF PATIENTS FOR NON-SMALL-CELL PULMONARY CANCER OF III STAGE | 2004 |
|
RU2270706C2 |
METHOD OF LUNG CANCER TREATMENT | 2014 |
|
RU2554750C1 |
METHOD OF COMBINATION TREATMENT OF PATIENTS WITH LOCALLY ADVANCED STOMACH CANCER | 2011 |
|
RU2461375C1 |
METHOD FOR REHABILITATION TREATMENT OF ONCOGYNAECOLOGIC PATIENTS OF REPRODUCTIVE AGE SUFFERING UTERINE CORPUS AND CERVICAL CANCER AND RECEIVED ANTICANCER THERAPY | 2014 |
|
RU2548506C1 |
METHOD OF TREATMENT BREAST CANCER | 2008 |
|
RU2393888C1 |
METHOD OF TREATMENT OF PATIENTS WITH LOCAL NON-SMALL CELL LUNG CANCER | 2007 |
|
RU2361580C2 |
Authors
Dates
2007-08-20—Published
2004-10-20—Filed